Specifying """"""""good"""""""" nutrition or the appropriate level of nutrients in either the clinical setting or in healthy normal individuals is dependent upon our knowledge of the basic biochemistry and metabolism of the nutrients being administered. Included in this nutritional database must also be knowledge of how the body regulates flows and stores of the critical elements of energy and protein metabolism in health and disease. This understanding should be mandatory before new enteral or parenteral feeding solution are proposed with novel combinations of nutrients. Yet this advice is often ignored. The long term goals of this proposal continue to be studies of amino acid and protein metabolism in humans to elucidate how the body regulates amino acids and protein in the body, how it handles dietary intake, and how other nutrients (e.g. carbohydrate and fat) interact with them. Our approach has been to administer stable isotopically labeled amino acid tracers to determine amino acid and protein kinetics in healthy individuals. There are 2 arms to these studies: (a) determination of amino acid metabolism in normal individuals to define normal physiology and (b) to understand amino acid metabolism in states of pathophysiology (e.g. injury or metabolic disease) by mimicking in healthy individuals through administration of one or more hormones or other mediators the particular aspect of disease to be studied. This proposal has 3 aims: (1) To define of how dietary amino acids are utilized by the splanchnic bed in the fed state. These studies will address the importance of the hormones insulin and glucagon versus substrate signals in mediating splanchnic bed utilization of amino acids. (2) To define the role of glucagon in disposal of amino acids coming from muscle and other peripheral tissues, particularly glutamine and alanine, for production of glucose. (3) To define whether therapeutic analogues of cortisol used for treatment of inflammation and immune suppression produce similar increases in resting energy expenditure as we have defined for cortisol.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK038429-07A2
Application #
2140520
Study Section
Nutrition Study Section (NTN)
Project Start
1986-08-01
Project End
1997-12-31
Budget Start
1994-01-01
Budget End
1994-12-31
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Holm, Lars; O'Rourke, Bruce; Ebenstein, David et al. (2013) Determination of steady-state protein breakdown rate in vivo by the disappearance of protein-bound tracer-labeled amino acids: a method applicable in humans. Am J Physiol Endocrinol Metab 304:E895-907
Holm, Lars; Kjaer, Michael (2010) Measuring protein breakdown rate in individual proteins in vivo. Curr Opin Clin Nutr Metab Care 13:526-31
Previs, Michael J; VanBuren, Peter; Begin, Kelly J et al. (2008) Quantification of protein phosphorylation by liquid chromatography-mass spectrometry. Anal Chem 80:5864-72
Matthews, Dwight E (2007) An overview of phenylalanine and tyrosine kinetics in humans. J Nutr 137:1549S-1555S;discussion 1573S-15
Jennings 2nd, Mark E; Matthews, Dwight E (2005) Determination of complex isotopomer patterns in isotopically labeled compounds by mass spectrometry. Anal Chem 77:6435-44
Matthews, Dwight E (2005) Observations of branched-chain amino acid administration in humans. J Nutr 135:1580S-4S
MacCoss, Michael J; Matthews, Dwight E (2005) Quantitative MS for proteomics: teaching a new dog old tricks. Anal Chem 77:294A-302A
Wu, Christine C; MacCoss, Michael J; Howell, Kathryn E et al. (2004) Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal Chem 76:4951-9
Shinebarger, Steven R; Haisch, Michael; Matthews, Dwight E (2002) Retention of carbon and alteration of expected 13C-tracer enrichments by silylated derivatives using continuous-flow combustion-isotope ratio mass spectrometry. Anal Chem 74:6244-51
Toth, M J; MacCoss, M J; Poehlman, E T et al. (2001) Recovery of (13)CO(2) from infused [1-(13)C]leucine and [1,2-(13)C(2)]leucine in healthy humans. Am J Physiol Endocrinol Metab 281:E233-41

Showing the most recent 10 out of 34 publications